Covid-19 roundup: White House reveals vaccine donation plan; EU opts in for another 150 million doses from Moderna
President Joe Biden’s administration on Monday revealed the distribution list for 55 million of the 80 million doses of Covid-19 vaccines America plans to donate to lower-income nations:
- Roughly 14 million doses will head to Latin America and the Caribbean, for a list of countries that includes Brazil, Argentina, Dominican Republic, Panama and Costa Rica.
- Another 16 million doses are headed to Asia to help the following countries: India, Nepal, Bangladesh, Pakistan, Sri Lanka, Afghanistan, Maldives, Bhutan, Philippines, Vietnam, Indonesia, Thailand, Malaysia, Laos, Papua New Guinea, Taiwan, Cambodia, and the Pacific Islands.
About 10 million doses are headed to Africa to share with a list of countries that will be determined by the African Union.
“Our goals are to increase global Covid-19 vaccination coverage, prepare for surges and prioritize healthcare workers and other vulnerable populations based on public health data and acknowledged best practice, and help our neighbors and other countries in need,” the press release said. “And, as we have previously stated, the United States will not use its vaccines to secure favors from other countries.”
EU orders 150M more doses of Moderna’s shot
Another 150 million doses of Moderna’s vaccine are headed to the EU, the commission said Tuesday, after it decided to pick up an option for more doses.
The announcement comes after CureVac’s Covid-19 vaccine flopped, with trial data showing just 47% efficacy and causing questions for countries who already inked deals with the German drugmaker.
The option was a part of the EU’s strategy to build a stock of vaccines for future use against variants. The bloc said the decision was not linked to the CureVac announcement, Reuters reported. The EU also signed a contract with Pfizer for 1.8 billion doses of its vaccine until 2023.
Moderna’s additional doses will be delivered next year and will help the 27-country bloc provide jabs for children and boosters.
2 new European sites approved to make Pfizer/BioNTech vaccine
Pfizer and BioNTech have gained approval from the EMA for two more manufacturing sites in Europe, the agency announced Tuesday.
A site in Reinbek, Germany, is operated by Allergopharma GmbH, and another in Stein, Switzerland, operated by Novartis will carry out fill-finish. The sites are now operational immediately, as they do not require any decision from the European Commission.
For a look at all Endpoints News coronavirus stories, check out our special news channel.